Location: Home > Pharma China Web Edition
  • search
  • go
  • Industry News
  • 1/12/2025Imunopharm Secures Series E Financing to Support IM19 Commercializatio...
  • 1/11/2025Suzhou Hemacell Biotech Secures Multi-Million CNY Investment to Advanc...
  • 1/11/2025Avenzo and DualityBio Announce Exclusive Global Deal for EGFR/HER3 AD...
  • 1/11/2025BrainAurora Debuts on Hong Kong Stock Exchange as First Neurotech IPO ...
  • 1/7/2025Cure Genetics Secures Series B Financing to Drive CGT Innovations
  • 1/7/2025Junshi Secures NMPA Approval for Toripalimab in 2nd-Line Melanoma Trea...
  • 1/7/2025Gene Vector Secures Strategic Financing
  • 1/7/2025Insilico Medicine Secures Over $100M in Equity Financing to Advance AI...
  • 1/6/2025Solasia Pharma Partners with GenSci to Boost Sales of Episil in China
  • 1/6/2025I-Mab Reprioritizes Pipeline and Halts CD73 Development
  • 1/6/2025WuXi Bio Divests Irish Vaccine Facility to Merck Amid Potential U.S. R...
  • 1/3/2025Prime Gene Therapeutics Completes Over CNY 300M in Series B Financing
  • 1/3/2025Eli Lilly China Launches Zepbound (tirzepatide) for Diabetes and Weigh...
  • 1/3/2025HighLightHill Pharma Secures CNY 150M in Series Pre-C Financing
  • 1/3/2025WuXi Biologics and Sino Biopharm Partner on mAb Discovery
  • 1/3/2025New Horizon Health Faces Deeper Crisis as Chairman and CEO Step Down
  • 1/3/2025Brii Biosciences Acquires BRII-179 Assets from VBI Vaccines
  • 1/2/2025Hutchmed Announces $608M Non-core Chinese Unit Stake Sale
  • 1/2/2025Roche and Innovent Enter Global License Deal for Novel DLL3 ADC 
  • 12/30/2024Reforgene Secures Major Financing to Advance Gene-Editing Therapies
  • 12/30/2024CARsgen Reports Positive Topline Results from China GC/GEJ Pivotal Pha...
  • 12/30/2024Duality Announces B7H4 ADC Milestone and License Exercise by BeiGene
  • 12/30/2024Solasia Struggles to Finalize China Deal, Lowers 2024 Financial Guidan...
  • 12/30/2024 India Deepens Ties with Chinese Biotech: Cipla and Mankind Lead the W...
  • 12/29/2024CSRC Approves Ascentage Pharma's U.S. IPO Filing
  • 12/29/2024Hong Kong Accepts IPO Application from GenFleet Therapeutics
  • 12/29/2024IDEAYA Biosciences Enters Exclusive License with Hengrui Pharma for AD...
  • 12/27/2024AusperBio Secures $73M in Series B Financing to Advance Functional Cur...
  • 12/25/2024Huaota Biopharma Secures CNY 200M in Financing to Drive R&D
  • 12/25/2024Hechuang Biotech Secures Series A Funding to Advance CGT Research
  • Page:17/25 Total number of articles:735: [First][<<] [15] [16] [17] [18] [19] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group